Abstract:Rationale: Dilated cardiomyopathy (DCM) is a leading cause of heart failure and have a genetic basis in 20-30% of cases. Genetic studies in familial DCM have found mutations identified in more than 30 genes. However, the genetics of sporadic DCM is still unknown. Objective: To provide new insights into the pathophysiology of sporadic DCM, a mutational screening on 30 DCM-causing genes in a cohort was performed. Methods and Results: Patients diagnosed with idiopathic DCM were recruited into the study and underwent clinical evaluation. Genomic DNA was isolated from the peripheral blood and then 30 genes ( ACTC, DES, SGCD, MYH7, TNNT2, TPM1, TTN, VCL, MYBPC3, CSRP3, ACTN2, PLN, LDB3, MYH6, ABCC9, TNNC1, TCAP, TNNI3, EYA4, TMPO, PSEN1/2, CRYAB, PDLIM3, MYPN, LAMA4, ILK, ANKRD1, RBM20, LMNA , and SCN5A ) of every sample were detected by next-generation sequencing. All called variants were compared against National Center for Biotechnology Information SNP Database build 137 and the March 2012 release of the 1000 Genomes project. All variants identified in the cohort were compared in ethnic-matched controls consisting of 197 adult Chinese from the 1000 Genomes. The pathogenicity of the variants absent from controls were evaluated by SIFT software. Sixty-six adult Chinese unrelated DCM patients were tested for up to 30 genes causing familial DCM. The mean age was 49.14±15.97 years. Every patient was detected nonsynonymous variants, and the total 87 variants were composed of 39 novel and 48 known. Among the whole 87 variants, 34 satisfied the criteria (1) absent from ethnic-matched controls and (2) altering evolutionary conservation of amino acid verified by SIFT analysis, which were considered pathogenic mutations, identified in 30 patients accounting for 45.45% of the cohort. The 2 most frequent genes involved in mutation positive patients were SCN5A (12.12%) and MYH7 (10.61%). Conclusions: Mutant genes found in familial DCM were also common in sporadic DCM, and the discovery of novel mutations spanned the spectrum of DCM genetics, implicating that genetic etiologies play an important role in pathogenesis of sporadic DCM.

Prevalence and spectrum of GATA4 mutations associated with sporadic dilated cardiomyopathy.

GATA4 Loss-of-function Mutation Underlies Familial Dilated Cardiomyopathy.

A Novel GATA4 Loss-of-function Mutation Responsible for Familial Dilated Cardiomyopathy

GATA5 Loss-of-function Mutation in Familial Dilated Cardiomyopathy.

Gata6 Loss-Of-Function Mutations Contribute To Familial Dilated Cardiomyopathy

Association Between SCN5A R225Q Variant and Dilated Cardiomyopathy: Potential Role of Intracellular Ph and WNT/β-catenin Pathway

Prevalence And Spectrum Of Nkx2-5 Mutations Associated With Sporadic Adult-Onset Dilated Cardiomyopathy

TBX20 Loss-of-function Mutation Associated with Familial Dilated Cardiomyopathy.

Prevalence and Spectrum of LRRC10 Mutations Associated with Idiopathic Dilated Cardiomyopathy.

Analysis of the mutational spectrum of TBX20 associated with sporadic dilated cardiomyopathy

TBX5 Loss-of-function Mutation Contributes to Familial Dilated Cardiomyopathy

Identification of Functional Mutations in GATA4 in Patients with Congenital Heart Disease

Abstract 050: Mutational Spectrum in a Cohort of Chinese Sporadic Dilated Cardiomyopathy by Next-generation Sequencing

ZBTB17 Loss-of-function Mutation Contributes to Familial Dilated Cardiomyopathy

HAND1 loss-of-function mutation associated with familial dilated cardiomyopathy.

A Novel Gata4 Mutation Responsible for Congenital Ventricular Septal Defects

A Novel Tbx20 Loss-Of-Function Mutation Contributes to Adult-Onset Dilated Cardiomyopathy or Congenital Atrial Septal Defect

A Novel Nkx2-5 Loss-Of-Function Mutation Predisposes to Familial Dilated Cardiomyopathy and Arrhythmias

A Novel GATA6 Mutation in Patients with Tetralogy of Fallot or Atrial Septal Defect

Genetic and functional variants of the TBX20 gene promoter in dilated cardiomyopathy

Mutation Screening of Gata4 Gene in CTD Patients Within Chinese Han Population.